Objective: To determine an optimal cutoff level of a modified 100 g oral glucose tolerance test (OGTT) with its diagnostic performance for gestational diabetes mellitus (GDM).
Introduction
Gestational diabetes mellitus (GDM) is a common metabolic derangement that occurs during pregnancy, and is associated with an increased risk of obstetric complications such as preeclampsia, cesarean delivery and fetal macrosomia. [1] [2] [3] [4] Detection of this condition would lead to an appropriate treatment, resulting in an improvement of pregnancy outcome. 5, 6 In 1964, O'Sullivan and Mahan 7 originally proposed a 100 g, 3 h oral glucose tolerance test (OGTT) using whole blood sample as a diagnostic method of GDM. Subsequent authors applied plasma or serum instead of whole blood, and modified some techniques and diagnostic criteria. For example, different amounts of loading glucose as well as various cutoff values for diagnosis were used. [8] [9] [10] Although there are still some controversies among expert opinions regarding the diagnostic criteria, at least three international criteria are currently considered as the 'gold standard': those of the National Diabetes Data Group (NDDG), the Carpenter and Coustan, and the World Health Organization. [8] [9] [10] [11] The recent American College of Obstetricians and Gynecologists guidelines recommended the diagnostic criteria set forth by either the NDDG or the Carpenter and Coustan thresholds. 1 We have followed this recommendation and the NDDG criteria is currently used in our institution.
A 100 g OGTT consists of four plasma glucose measurements, which requires a total duration of 3 h to accomplish the procedure. 1 In a practical point of view, many factors such as time consuming, cost and number of venipuncture may contribute to the limitation of test achievement. 12, 13 Thus, attention has been focused on alternative approaches to simplify the diagnostic algorithm. One earlier report demonstrated that more than 80% of pregnancies with GDM had 1 or 2 h OGTT values above upper normal limit.
14 Derived from such data, we modified 100 g OGTT by determining a summation of 1 and 2 plasma glucose levels after 100 g glucose ingestion for a diagnosis of GDM. The objective of this study was to evaluate the optimal cutoff level of this summed glucose, with its diagnostic performance for GDM.
Methods
This study obtained an approval of the Bangkok Metropolitan Administration Ethics Committee for research involving human subjects. Obstetric records of women who attended the antenatal clinic of the Department of Obstetrics and Gynecology in our institution were reviewed. During a 16-month period (January 1, 2005-April 30, 2006), all pregnant women without preexisting overt diabetes were routinely screened for GDM with a 50 g glucose challenge test. Those without any risk factor for GDM were screened between 24 and 28 weeks of gestation, while women at risk were tested at an initial visit. Risk factors included age X35 years, body mass index>27 kg m À2 , family history of diabetes mellitus in any of first-degree relatives, history of large neonate (X4000 g), history of adverse perinatal outcome (Xtwo miscarriages, congenital malformation or stillbirth) and glucosuria. Women with abnormal glucose challenge test results, being defined as plasma glucose levels X140 mg 100 ml À1 , would be scheduled for a diagnostic 100 g OGTT. Before undergoing the OGTT, the women were instructed to consume carbohydrate-rich food for 3 days. Subsequently, after an overnight fast for 10-12 h, blood samples during fasting and three consecutive hourly post 100 g glucose intake were drawn for plasma glucose determinations. All OGTT specimens were estimated by glucose oxidase method using the same automated analyzer model Synchron LX20 (Beckman Coulter Inc., Fullerton, CA, USA). The Precipath U control (Roch Diagnostics Corp., Indianapolis, IN, USA) was used to calibrate the machine each morning for a daily quality assurance. The overall results of the control samples fell inside a normal range (target value±three standard deviations (SDs)). The NDDG criteria were used as the 'gold standard' for diagnosing GDM. 8 A diagnosis was made when two or more abnormal glucose values were met: fasting value X105 mg 100 ml À1 ; 1 h value X190 mg 100 ml À1 ; 2 h value X165 mg 100 ml À1 and 3 h value X145 mg 100 ml À1 . 8 Eligibility criteria were all pregnant women who had had abnormal 50 g glucose challenge tests, and who underwent a 100 g OGTT at the institution between January 2005 and April 2006. Individuals with history of GDM in prior pregnancy were excluded to avoid a condition of unrevealed overt diabetes. The women who were lost to follow-up or those whose obstetric charts had incomplete clinical data were also excluded. Information on maternal age, parity, prepregnancy weight, height, body mass index, risk factors for GDM, gestational age at which 100 g OGTT was performed and all four OGTT values were collected. Body mass index was calculated as weight (kg) divided by square of height (m 2 ). A modified 100 g OGTT was proposed using a summation of 1 and 2 h plasma glucose levels, which were taken from a conventional 100 g OGTT performed in the study group. Each of the two authors independently interpreted the conventional and modified OGTTs as positive or negative tests. The k coefficients for inter-observer agreement on the interpretation of the conventional and modified OGTTs were 0.98 and 0.99, respectively.
Statistical analysis was performed with the SPSS software package version 11.5 (SPSS Inc., Chicago, IL, USA). The Stata 7.0 (Stata Corp., College station, TX, USA) was used to generate confidence intervals (CIs). Continuous variables were presented as mean with s.d. or median with range, and categorical variables as number with percentage. The sensitivity, specificity, positive predictive value and negative predictive value with associated 95% CIs at various cutoff levels of the summed 1 and 2 h plasma glucose were calculated using the NDDG criteria as the gold standard. A receiver operating characteristic curve was constructed and the area under the curve was then calculated to determine the optimal cutoff level for making a diagnosis of GDM.
Results
Total of 909 complete obstetric charts from 956 women who underwent a 100 g OGTT during the study period were identified. Almost all pregnancies were Thai with a few Southeast Asian. Mean age ( ± s.d.) of the women was 29.5 ± 6.0 years. Four hundred fifty-seven out of 909 pregnancies (50.3%) were nulliparous. Majority of women (68.8%) had at least one risk factor for GDM. Details of the population characteristics are shown in Table 1 .
The 100 g OGTT was performed at a median gestational age of 26 weeks (range 6-40 weeks). Median fasting, 1, 2 and 3 h plasma glucose values were 83 mg 100 ml À1 (range 53-262 mg 100 ml À1 ), 155 mg 100 ml À1 (range 68-467 mg 100 ml À1 ), 130 mg 100 ml À1 (range 50-554 mg 100 ml À1 ) and 109 mg 100 ml À1 (range 44-455 mg 100 ml À1 ), respectively. According to the NDDG criteria, 155 women (17.1%) were classified as GDM. The diagnosis was made during early gestation in 67 women (43.2%), and was detected in late second-to third trimester in 88 women (56.8%) due to their delay for the first antenatal care. Among the 155 GDM women, 89 (57.4%) had GDM of class A 1 and had only diet control. Of 66 women (42.6%) who were classified as class A 2 , 39 had well-controlled plasma glucose levels with diet modification, while 27 required insulin therapy. The results of glucose values from the OGTT and the numbers of women with Modified 100 g oral glucose tolerance test C Phaloprakarn and S Tangjitgamol abnormal plasma glucose at each hour, categorized by a GDM diagnosis according to the NDDG criteria, are shown in Table 2 . We added up 1 and 2 h plasma glucose levels; median value of which was 284 mg 100 ml À1 (range 138-1021 mg 100 ml À1 ). Median summed glucose value of women with GDM was significantly higher than that of women without GDM, 386 mg 100 ml À1 (range 305-1021 mg 100 ml À1 ) compared to 272 mg 100 ml À1 (range 138-404 mg 100 ml À1 ) (P<0.001). We analyzed the summed plasma glucose (at every 1 mg 100 ml À1 increment) to find the optimal cutoff level of the modified OGTT for GDM diagnosis. The receiver operating characteristic curve of the modified OGTT is demonstrated in Figure 1 . Selected cutoff levels of a summation of the glucose values with high diagnostic performances are also shown in Table 3 . We discovered that a cutoff level of X341 mg 100 ml À1 yielded the best diagnostic performance for GDM; the sensitivity, specificity, positive predictive value and negative predictive value were 93.5% (95% CI 88.5 to 96.9), 95.2% (95% CI 93.4 to 96.6), 80.1% (95% CI 73.5 to 85.7) and 98.6% (95% CI 97.5 to 99.3), respectively. At this optimal value, the area under the curve was 0.94 (95% CI 0.92 to 0.97).
Based on the cutoff level of 341 mg 100 ml À1 from our modified 100 g OGTT, 10 women (6.5%) with GDM according to the conventional criteria would be missed. Their summed plasma glucose values ranged from 305 to 337 mg 100 ml À1 . Seven cases had class A 1 GDM and three were classified as A 2 . One of the latter group required insulin treatment while the other two had nutritional control and were under close surveillance of the obstetricians and endocrinologists.
Details of birth outcomes including large neonate (X4000 g), cesarean section due to cephalopelvic disproportion and operative vaginal delivery of women with and without GDM according to criteria of the NDDG and modified OGTT are shown in Table 4 .
Discussion
A 100 g OGTT is a widely accepted standard method of GDM diagnosis. However, there are still some disadvantages of the procedure such as time consuming, cost from many glucose Abbreviations: GDM, gestational diabetes mellitus; OGTT, oral glucose tolerance test. a 15/49 women with abnormal fasting glucose had levels of glucoseX126 mg 100 ml À1 , and also had at least two abnormal non-fasting glucose values. b Only 1/15 women had fasting glucose level of 174 mg 100 ml À1 but was diagnosed as non-GDM due to normal second fasting glucose test on the following day. All other 14 women who had abnormal fasting glucose had glucose values <126 mg 100 ml À1 . Figure 1 The receiver operating characteristic curve of the modified oral glucose tolerance test for a gestational diabetes mellitus diagnosis.
Modified 100 g oral glucose tolerance test C Phaloprakarn and S Tangjitgamol measurements and number of venipuncture. 12, 13 Many strategies that have been attempted to modify a conventional 100 g OGTT demonstrated variable results. Atilano et al. 15 pioneered an abbreviated approach by omission of the 3 h value from a 100 g OGTT in 512 pregnant women. Their failure rate to detect GDM was as high as 13%. In contrast, studies of Jakobi et al. 16 in 876 women and Rodacki et al.
14 in 65 women reported that only a fraction (p2%) of GDM would be missed by an exclusion of this 3 h value. The differences among these three studies might rest on various populations studied, sample sizes and different OGTT cutoff values used (that is, lower thresholds of all four glucose values of OGTT were used in the studies of Jakobi et al. and Rodacki et al.) .
In addition to an omission of the 3 h glucose measurement, other forms of abbreviated 100 g OGTT were investigated. From a study of 6801 pregnancies who underwent a conventional 100 g OGTT, Agarwal et al. 17 found that using the lone 2 h value yielded the best diagnostic performance with area under the curve of 0.93. However, the overall 83.6% sensitivity and 92.8% specificity were not optimal for clinical use. Nevertheless, the authors made an observation that an evaluation of both 2 h and fasting values at various levels would yield better diagnostic performances and might be useful as an alternative approach for GDM diagnosis.
Majority of women with GDM in this study were diagnosed from two out of the three plasma glucose values post 100 g glucose intake ( Table 2 ). Owing to the low prevalence of abnormal fasting glucose value in our population (only 7%), any application that involved its measurement should not yield much benefit for the GDM diagnosis. Hence, we attempted to search for the other alternatives to diagnose GDM for our population by using any of the three hourly glucose values. Our results were in accordance with previous data of Rodacki et al.
14 that over 80% of women with GDM had 1 and 2 h OGTT levels above upper normal limit. By this observation, we primarily investigated whether any of the two plasma glucose values could be used. In corroboration with the study of Agarwal et al., 17 we found that using any of the two values alone did not yielded satisfactory diagnostic performance in both sensitivity and specificity (data are not shown). However, when using these two values in summation, we found a satisfactory result. At the optimal cutoff level of X341 mg 100 ml À1 , the sensitivity and specificity were as high as 93.5 and 95.2%, respectively. We also evaluated this modified OGTT in the other scenario when the Carpenter and Coustan criteria 1 would be used as the gold standard. From these glucose thresholds, 212/909 women would be diagnosed as GDM. With the same cutoff level (summed plasma glucose X341 mg 100 ml À1 ), we found a high specificity of 97.7% but a low sensitivity of only 77.8%. Thus, lower cutoff level of the summed plasma glucose of the modified OGTT must be searched for in the settings where the Carpenter and Abbreviations: CPD, cephalopelvic disproportion; GA, gestational age; GDM, gestational diabetes mellitus; n, number; NDDG, National Diabetes Data Group; OGTT, oral glucose tolerance test; s.d., standard deviation; -ve, negative; +ve, positive.
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Coustan criteria are generally practiced. This is beyond the scope of our study and would not be explored further in detail. One may question whether it would be appropriate to cancel out the fasting glucose determination for a modification of conventional OGTT. Our result showed that its measurement added up only a small percentage of women with GDM; almost all of the GDM women who had fasting glucose values exceeding upper normal limit (44 out of 49) also had other two abnormal glucose values, and would be diagnosed as GDM anyhow. However, this might lie on the low prevalence of abnormal fasting glucose in our population. An exclusion of such glucose determination in other areas where its prevalence of abnormality is high may not be suitable. Not of lesser importance are the roles of fasting plasma glucose in itself as a diagnostic criterion (X126 mg 100 ml À1 in two separate settings) 11 and to classify the GDM into subgroups. Thus at this point, we could not absolutely omit the fasting glucose component especially in a general population with different rate of abnormal fasting value. In the circumstance where the prevalence of abnormal fasting glucose is high, one proposed alternative is to obtain its measurement prior to a standard 50 g glucose challenge test, so that a woman who has a marked increase in its level would not be subjected to a 100 g glucose load.
Other diagnostic studies simply compared the accuracy of an offered test to the gold standard without examining perinatal effects. We presented birth outcomes of women who had or had not GDM based on the NDDG criteria and stratified them according to the results from the modified OGTT. One should be cautious in interpreting these results. Although the 10 women with falsenegative-modified OGTT (1.1% of 909 women) appeared to have no significant perinatal morbidities, all of these women were taken care and treated as GDM by the NDDG criteria. Besides, the absence of perinatal complications in these 10 women may be due to a lack of statistical power. Hence, the actual perinatal effects remain unproven until further prospective study in which women are randomized to either diagnostic method and are treated accordingly is carried out to compare the adverse outcomes. Nevertheless, we would like to point out that there were seven cases of large neonates (20%) among 35 women with false-positivemodified method. This adverse outcome might be reduced if this additional number of women would have been treated as GDM according to the modified criteria. However, any definite conclusion could not be made from our study that had only small number of women in this particular group, and we have to wait for the study with more number of women to verify this finding.
In conclusion, our study demonstrated a high diagnostic performance of the modified 100 g OGTT. With the obvious advantages over a conventional OGTT in terms of convenience and cost-effectiveness with a comparable diagnostic performance, this technique could be considered as an alternative for GDM diagnosis, particularly in settings where prevalence of the disorder is high and the cost is of concern. However, since our data were limited to a homogeneous population with high prevalence of GDM, further studies are warranted to confirm the findings in larger multiethnic groups or in the other areas where rates of GDM are different, as well as to investigate whether this technique could be applied when different diagnostic criteria of GDM are used.
